nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anlotinib enhances the pro-apoptotic effect of APG-115 on acute myeloid leukemia cell lines by inhibiting the P13K/AKT signaling pathway
|
Zhao, Rui |
|
|
149 |
C |
p. |
artikel |
2 |
A novel KMT2A::DCP1A fusion gene in acute myeloid leukemia
|
Deng, Ailing |
|
|
149 |
C |
p. |
artikel |
3 |
Editorial Board
|
|
|
|
149 |
C |
p. |
artikel |
4 |
Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia
|
Fontecha, María Belén |
|
|
149 |
C |
p. |
artikel |
5 |
Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial
|
Kan, Suisui |
|
|
149 |
C |
p. |
artikel |
6 |
New treatments for adult T-cell leukemia/lymphoma
|
Epstein-Peterson, Zachary D. |
|
|
149 |
C |
p. |
artikel |
7 |
Targeted antibody therapy as a treatment strategy for aggressive adult T-cell leukemia/lymphoma
|
Yoshimitsu, Makoto |
|
|
149 |
C |
p. |
artikel |
8 |
The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
|
Cho, Hanwool |
|
|
149 |
C |
p. |
artikel |
9 |
The relationship between clinical prognostic factors, microvascular density, and tumor-infiltrating lymphocytes with CD47 and SIRPα expression in diffuse large B cell lymphomas
|
Kılıçarslan, Aydan |
|
|
149 |
C |
p. |
artikel |